Cleared Traditional

K203280 - Hepatica v1 (Hepatica v1.0.0)

K203280 is the FDA 510(k) clearance for Hepatica v1 (Hepatica v1.0.0) by Perspectum, Ltd.. It is a Class 2 Radiology device (product code LNH) cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K203280 · Perspectum, Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
67d
Days
Class 2
Risk

K203280 is an FDA 510(k) clearance for the Hepatica v1 (Hepatica v1.0.0). Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Perspectum, Ltd. (Oxford, GB). The FDA issued a Cleared decision on January 12, 2021 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Perspectum, Ltd. devices

Submission Details

510(k) Number K203280 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2020
Decision Date January 12, 2021
Days to Decision 67 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 107d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 812
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K203280.
Vantage Galan 3T, MRT-3020, V7.0 with AiCE Reconstruction Processing Unit for MR
K203553 · Canon Medical Systems Corporation · Feb 2021
i_Space 1.5T Superconducting Magnetic Resonance Imaging System
K192650 · Mri Division,Beijing Wandong Medical Technology Co., Ltd. · Jan 2021
Vantage Orian 1.5T, MRT-1550, V6.0
K202767 · Canon Medical Systems Corporation · Jan 2021
HepaFat-AI
K201039 · Resonance Health Analysis Services Pty, Ltd. · Dec 2020
Vantage Orian 1.5T, MRT-1550, V7.0 with AiCE Reconstruction Processing Unit for MR
K203053 · Canon Medical Systems Corporation · Dec 2020
SIGNA Architect
K202966 · Ge Healthcare (Ge Medical Systems, LLC) · Nov 2020